关注
Ines Neundorf
Ines Neundorf
未知所在单位机构
在 eunapplication.org 的电子邮件经过验证
标题
引用次数
年份
TANGO1 inhibitors reduce collagen secretion and limit tissue scarring
I Raote, AH Rosendahl, HM Häkkinen, C Vibe, I Küçükaylak, M Sawant, ...
Nature Communications 15 (1), 3302, 2024
2024
Investigating the impact of thiol reactivity and disulfide formation on cellular uptake of cellpermeable peptides
M Klußmann, K Stillger, M Ruppel, CL Sticker, I Neundorf
Journal of Peptide Science, e3604, 2024
2024
Interaction with AK2A links AIFM1 to cellular energy metabolism
RA Rothemann, E Pavlenko, M Mondal, S Gerlich, P Grobushkin, ...
bioRxiv, 2024.09. 09.611957, 2024
2024
Triazole-Bridged Peptides with Enhanced Antimicrobial Activity and Potency against Pathogenic Bacteria
J Grabeck, J Mayer, A Miltz, M Casoria, M Quagliata, D Meinberger, ...
ACS Infectious Diseases, 2024
2024
Modified CLEC3A-Derived Antimicrobial Peptides Lead to Enhanced Antimicrobial Activity against Drug-Resistant Bacteria
D Meinberger, MG Drexelius, J Grabeck, G Hermes, A Roth, D Elezagic, ...
Antibiotics 12 (10), 1532, 2023
32023
Rational design of bifunctional chimeric peptides that combine antimicrobial and titanium binding activity
M Drexelius, R Arnold, D Meinberger, M Wilhelm, S Mathur, I Neundorf
Journal of Peptide Science 29 (8), e3481, 2023
12023
Cell-permeable peptide-based delivery vehicles useful for subcellular targeting and beyond
K Stillger, I Neundorf
Cellular Signalling, 110796, 2023
52023
Comparing variants of the cell-penetrating peptide sC18 to design peptide-drug conjugates
J Grabeck, T Lützenburg, P Frommelt, I Neundorf
Molecules 27 (19), 6656, 2022
52022
Synthetic αHelical Peptides as Potential Inhibitors of the ACE2 SARSCoV2 Interaction
PM Engelhardt, S FlorezRueda, M Drexelius, JM Neudörfl, D Lauster, ...
ChemBioChem 23 (17), e202200372, 2022
102022
AIFM1 is a component of the mitochondrial disulfide relay that drives complex I assembly through efficient import of NDUFS5
SL Salscheider, S Gerlich, A CabreraOrefice, E Peker, RA Rothemann, ...
The EMBO Journal 41 (17), e110784, 2022
202022
A peptide inhibitor of the human cytomegalovirus core nuclear egress complex
S Alkhashrom, J Kicuntod, K Stillger, T Lützenburg, C Anzenhofer, ...
Pharmaceuticals 15 (9), 1040, 2022
102022
Multistep translation of a cell-penetrating peptide into an antimicrobial peptide
M Drexelius, I Neundorf
17 Naples Workshop on Bioactive Peptides, 42, 2022
2022
Development and biochemical characterization of self-immolative linker containing GnRH-III-drug conjugates
S Schuster, É Juhász, G Halmos, I Neundorf, C Gennari, G Mező
International Journal of Molecular Sciences 23 (9), 5071, 2022
102022
Hollow mesoporous silica capsules loaded with copper, silver, and zinc oxide nanoclusters for sustained antibacterial efficacy
E Krakor, S Saniternik, I Gessner, R Frohnhoven, M Wilhelm, M Drexelius, ...
Journal of the American Ceramic Society 105 (3), 1685-1696, 2022
102022
Different approaches to cyclize a cell-penetrating peptide and to tether bioactive payloads
L Feni, I Neundorf
Peptide Macrocycles: Methods and Protocols, 375-389, 2022
22022
Synthesis of cell-penetrating peptide coated silica nanoparticles and their physicochemical and biological characterization
I Gessner, A Klimpel, I Neundorf
Cell Penetrating Peptides: Methods and Protocols, 105-117, 2022
22022
Medical use of cell-penetrating peptides: how far have they come?
I Neundorf
Peptide and Peptidomimetic Therapeutics, 235-254, 2022
12022
Application of antimicrobial peptides on biomedical implants: Three ways to pursue peptide coatings
MG Drexelius, I Neundorf
International Journal of Molecular Sciences 22 (24), 13212, 2021
282021
Improving membrane activity and cargo delivery efficacy of a cell-penetrating peptide by loading with carboranes
T Lützenburg, N Burdina, MS Scholz, I Neundorf
Pharmaceutics 13 (12), 2075, 2021
22021
Macropinocytosis-inducible extracellular vesicles modified with antimicrobial protein CAP18-derived cell-penetrating peptides for efficient intracellular delivery
K Noguchi, M Obuki, H Sumi, M Klussmann, K Morimoto, S Nakai, ...
Molecular Pharmaceutics 18 (9), 3290-3301, 2021
232021
系统目前无法执行此操作,请稍后再试。
文章 1–20